Renal cancer, although still rare among individuals under 45 years of age, is on the rise in the general population. The risk and timing of subsequent renal cancer in survivors of childhood cancer is not well established. Using the SEER registry, we reported the incidence of subsequent malignant renal neoplasms after treatment for primary malignancy diagnosed under 20 years of age.
View Article and Find Full Text PDFFront Bioeng Biotechnol
September 2022
IEEE Trans Biomed Eng
September 2022
Annu Int Conf IEEE Eng Med Biol Soc
November 2021
Annu Int Conf IEEE Eng Med Biol Soc
November 2021
Med Biol Eng Comput
August 2021
Purpose: The COVID-19 pandemic has led to the cancellation or deferment of many elective cancer surgeries. We performed a systematic review on the oncological effects of delayed surgery for patients with localised or metastatic renal cell carcinoma (RCC) in the targeted therapy (TT) era.
Method: The protocol of this review is registered on PROSPERO(CRD42020190882).
Annu Int Conf IEEE Eng Med Biol Soc
July 2020
IEEE Trans Med Imaging
December 2020
Med Biol Eng Comput
March 2020
Annu Int Conf IEEE Eng Med Biol Soc
July 2017
Annu Int Conf IEEE Eng Med Biol Soc
July 2017
Annu Int Conf IEEE Eng Med Biol Soc
July 2017